2HOFFER M E,ALLEN K,KOPKE R D.Transtympanic versus sustained-release administration of gentamicin:kinetics,morphology and function[J].Laryngoscope,2001,111:1343-1357.
3BLAKLEY B W.Update on intratympanic gentamicin for Meniere's disease[J].Laryngoscope,2000,110(2 Pt 1):236-240.
4SILVERSTEIN H,ARRUDA J,ROSENBERG S I,et al.Direct round window membrane application of gentamicin in the treatment of Meniere's disease[J].Otolaryngol Head Neck Surg,1999,120:649-655.
5BALKEY B W. Update on intratympanic gentamicin for Meniere's disease[J]. Laryngoscope, 2000, 110:236- 240.
6HARNER S G, DRISCOLL C L, FACER G W, et al. Long-term follow-up of transtympanie gentamieinfor Menere's syndrome[J]. Otol Neurotol, 2001, 22:210-214.
7WU I C, MINOR L B. Long-term hearing outcome in patients receiving intratympanic gentamicin for Meniere's disease[J]. Laryngoscope, 2003, 113:815 -820.
8PENDER J D. Gentamicin tympanoclyisis effects on the labyrinthine sensory cells [J]. Laryngoscope,2003, 113:343-348.
9Commttee on earing and equilibrium. Committee on hearing and equilibrium guildelines for the diagnosis and evaluation of therapy in Meniere's disease[J].Otolaryngol Head Neck Surg, 1995, 113:181-185.
10MINOR L B. Intratympanic gentamicin for control of vertigo in Meniere's disease: vestibular signs that specify completion of therapy[J]. Am J Otol, 1999,20:209-219.
3Rajan Gp,Dins,Atlas MD.Long-term effects of the Menitti device in Meniere's disease:the Western austrilian experience[J].J Laryngolo- tol,2005,119:391-395.
4Haynes DS,O'Malley M,Cohen S,et al.lntratympanic dexamethasone for sudden sen- sorineural hearing loss after failure of systemic therapy[J]. Laryngoscope, 2007,117: 3-15.
5Sajjadi H. Medical management of Meniere's disease[J].Otolaryngol Clin North Am,2002,35:581- 589.
6Newman CW, Jacobson GP, Spitzer JB.Development of the tinnitus handicap inventory.Arch Otolaryn- gol Head Neck Surg,1996,122.143-148.
7Itoh A,Sakata E.Treatment of vestibular disorders. Acta Otolaryngol Suppl, 1991,481:617-623.
8Rupprecht R, Reul JM, Van Steensel B, et m. Pharmacological and functional chraracterization of human mineralocorticoid and glucocorticoid recep- tor ligands.Eur J Pharmacol,1993,247,145-154.
9Smith PJ, Cousins DJ, Jee YK, et al. Suppres- sion of granulocyte macrophage colony stimulating factor expression by glucocorticoids involves in- hibition of enhancer function by the glucocorti- cold receptor binding to composite NF-AT/activator proteinl elements. J Immunol, 2002,167:2502-2510.
10Garduno-anaya MA,Louthino DE,Toledo H, et al. Dexamethasone inner ear perfusion by intratym- panic injection in unilateral Meniere's disease, a two-year prospective, placebo-controlled, double- blind, randomized trial. Otolaryngol Head Neck Surg, 2005,133:285-294.
